Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Pulmonary Hypertension

Free Subscription 15.04.2024 1 Acta Paediatr 1 Aging (Albany NY) 1 Am J Hematol 2 Am J Physiol Lung Cell Mol Physiol 1 BMJ Open Respir Res 2 Chest 2 Chin Med J (Engl) 1 Cureus 1 Drug Des Devel Ther 1 Eur J Immunol 1 Eur J Pediatr 2 Eur Respir J 1 Front Pediatr 1 Front Vet Sci 1 Heart Lung Circ 1 Immun Inflamm Dis 1 J Am Soc Echocardiogr 1 J Cardiothorac Vasc Anesth 1 J Cardiovasc Pharmacol 1 J Med Econ 1 J Pediatr Pharmacol Ther 1 JACC Case Rep 1 PeerJ 1 Proc Natl Acad Sci U S A 1 Purinergic Signal 1 Respir Med 1 Thorax 1 Vascul Pharmacol

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Acta Paediatr

1. CHALIA M, Seager E, Rao A, Hannam S, et al
   Transient abnormal myelopoiesis requiring advanced neonatal intensive care treatment.
   Acta Paediatr. 2024 Feb 8. doi: 10.1111/apa.17142.
   PubMed         Abstract available
   
   

   
   Aging (Albany NY)

2. CHAI Y, Gu X, Zhang H, Xu X, et al
   Phoenixin 20 ameliorates pulmonary arterial hypertension via inhibiting inflammation and oxidative stress.
   Aging (Albany NY). 2024;16:5027-5037.
   PubMed         Abstract available
   
   

   
   Am J Hematol

3. NJOKU F, Pugh N, Brambilla D, Kroner B, et al
   Mortality in adults with sickle cell disease: Results from the sickle cell disease implementation consortium (SCDIC) registry.
   Am J Hematol. 2024;99:900-909.
   PubMed         Abstract available
   
   

   
   Am J Physiol Lung Cell Mol Physiol

4. ALI M, Choudhary R, Singh K, Kumari S, et al
   Hypobaric hypoxia modulated structural characteristics of circulating cell-free DNA in high-altitude pulmonary edema.
   Am J Physiol Lung Cell Mol Physiol. 2024;326:L496-L507.
   PubMed         Abstract available
   
   
5. HATABAH D, De Marco T, McGlothlin DP, Malloy M, et al
   Low global arginine bioavailability: a common phenomenon in pulmonary hypertension.
   Am J Physiol Lung Cell Mol Physiol. 2024;326:L514-L515.
   PubMed        
   
   

   
   BMJ Open Respir Res

6. YOUSSEF M, Boutros Salama M, Rehman N, Hanna C, et al
   Pulmonary hypertension survival and hospitalisations in people living with HIV: a systematic review and meta-analysis.
   BMJ Open Respir Res. 2024;11:e002318.
   PubMed         Abstract available
   
   

   
   Chest

7. KEARNEY K, Brown K, Celermajer DS, Collins N, et al
   Impact of Left Heart Disease Risk Factors on Outcomes in Pulmonary Arterial Hypertension Therapy.
   Chest. 2024;165:967-977.
   PubMed         Abstract available
   
   
8. AL-NAAMANI N, Thenappan T
   Left Heart Disease Phenotype in Pulmonary Arterial Hypertension: Considerations for Therapy.
   Chest. 2024;165:766-768.
   PubMed        
   
   

   
   Chin Med J (Engl)

9. YE P, Deng Y, Gu Y, Liu P, et al
   GRK2-YAP signaling is implicated in pulmonary arterial hypertension development.
   Chin Med J (Engl). 2024;137:846-858.
   PubMed         Abstract available
   
   
10. WANG T, Zhou D, Chen Y, Kuang S, et al
    Non-invasive estimation of pulmonary hypertension and clinical deterioration risk in pediatric congenital heart disease: Development and validation of predictive tools.
    Chin Med J (Engl). 2024 Apr 8. doi: 10.1097/CM9.0000000000003070.
    PubMed        
    
    

    
    Cureus

11. UGWENDUM D, Mbome Y, Arrey Agbor DB, Burkhanova U, et al
    Methylphenidate-Induced Non-ischemic Heart Failure With Reduced Ejection Fraction and Mild Pulmonary Hypertension.
    Cureus. 2024;16:e55604.
    PubMed         Abstract available
    
    

    
    Drug Des Devel Ther

12. PASIANA AD, Idrus HH, Purnamasari I
    Forsythoside B Mitigates Monocrotaline-Induced Pulmonary Arterial Hypertension via Blocking the NF-kappaB Signaling Pathway to Attenuate Vascular Remodeling [LETTER].
    Drug Des Devel Ther. 2024;18:1023-1024.
    PubMed        
    
    

    
    Eur J Immunol

13. KOUDSTAAL T, van den Bosch T, Bergen I, Lila K, et al
    Predominance of M2 macrophages in organized thrombi in chronic thromboembolic pulmonary hypertension patients.
    Eur J Immunol. 2024 Apr 9:e2350670. doi: 10.1002/eji.202350670.
    PubMed         Abstract available
    
    

    
    Eur J Pediatr

14. MEGIED MAAE, Abouelhassan MA, Hadwa ESAES
    Prognostic and diagnostic utility of interleukin-6 in pediatric pulmonary arterial hypertension - a case-control study.
    Eur J Pediatr. 2024;183:1637-1643.
    PubMed         Abstract available
    
    

    
    Eur Respir J

15. WOOLF B, Perry JA, Hong CC, Wilkins MR, et al
    Multi-biobank summary data Mendelian randomisation does not support a causal effect of IL-6 signalling on risk of pulmonary arterial hypertension.
    Eur Respir J. 2024;63:2302031.
    PubMed         Abstract available
    
    
16. GRYNBLAT J, Bogaard HJ, Eyries M, Meyrignac O, et al
    Pulmonary vascular phenotype identified in patients with GDF2 (BMP9) or BMP10 variants: an international multicentre study.
    Eur Respir J. 2024;63:2301634.
    PubMed         Abstract available
    
    

    
    Front Pediatr

17. CHAUDHARI T, Schmidt Sotomayor N, Maheshwari R
    Diagnosis, management and long term cardiovascular outcomes of phenotypic profiles in pulmonary hypertension associated with congenital diaphragmatic hernia.
    Front Pediatr. 2024;12:1356157.
    PubMed         Abstract available
    
    

    
    Front Vet Sci

18. SAKARIN S, Rungsipipat A, Roytrakul S, Jaresitthikunchai J, et al
    Proteomic analysis of the serum in dogs with pulmonary hypertension secondary to myxomatous mitral valve disease: the preliminary study.
    Front Vet Sci. 2024;11:1327453.
    PubMed         Abstract available
    
    

    
    Heart Lung Circ

19. PAPAGEORGIOU ST, Damdoumis S, Goulis D, Tzikas S, et al
    The Effect of Pulmonary Hypertension on Mortality and Intensive Care Unit Admission in Patients With SARS-CoV-2 Infection: A Systematic Review and Meta-Analysis.
    Heart Lung Circ. 2024 Apr 9:S1443-9506(24)00076.
    PubMed         Abstract available
    
    

    
    Immun Inflamm Dis

20. SHI TY, Wen XH, Meng J, Lu YW, et al
    Effect of IL-17 on pulmonary artery smooth muscle cells and connective tissue disease-associated pulmonary arterial hypertension.
    Immun Inflamm Dis. 2024;12:e1243.
    PubMed         Abstract available
    
    

    
    J Am Soc Echocardiogr

21. MURPHY SP, Deferm S, Yucel E, Urbut SM, et al
    Right Ventricular - Pulmonary Arterial Coupling and All-Cause Mortality in Patients with Mitral Annular Calcification Related Mitral Valve Dysfunction.
    J Am Soc Echocardiogr. 2024 Jan 20:S0894-7317(24)00011.
    PubMed        
    
    

    
    J Cardiothorac Vasc Anesth

22. YENIDOGANAY R, Rancati V, Yerly P, Lu H, et al
    Atrial Flow Regulator: Should We Be Afraid of It?
    J Cardiothorac Vasc Anesth. 2024;38:1284-1286.
    PubMed        
    
    

    
    J Cardiovasc Pharmacol

23. KUMARI K, Vishwakarma VK, Kumar K, Mridha AR, et al
    Effect of benidipine alone and in combination with bosentan and sildenafil in amelioration of pulmonary arterial hypertension in experimental model in rats.
    J Cardiovasc Pharmacol. 2024 Jan 17. doi: 10.1097/FJC.0000000000001541.
    PubMed         Abstract available
    
    

    
    J Med Econ

24. LAU E, Kotlyar E, Makanji Y, Yu DY, et al
    Comparative adherence of macitentan versus ambrisentan and bosentan in Australian patients with pulmonary arterial hypertension: a retrospective real-world database study.
    J Med Econ. 2024;27:596-604.
    PubMed         Abstract available
    
    

    
    J Pediatr Pharmacol Ther

25. KISKADDON A, Dang T, Mauriello D
    Tadalafil in Neonates and Infants With Pulmonary Hypertension Secondary to Bronchopulmonary Dysplasia.
    J Pediatr Pharmacol Ther. 2024;29:140-143.
    PubMed         Abstract available
    
    

    
    JACC Case Rep

26. ALBULUSHI A, Al-Asmi S, Al-Abri M, Al-Farhan H, et al
    The Road to Heart Transplant in a Patient With Cardiomyopathy, Shone Complex, and Severe Pulmonary Hypertension.
    JACC Case Rep. 2024;29:102323.
    PubMed         Abstract available
    
    

    
    PeerJ

27. WEI X, Zou Y, Dong S, Chen Y, et al
    Recombinant hirudin attenuates pulmonary hypertension and thrombosis in acute pulmonary embolism rat model.
    PeerJ. 2024;12:e17039.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

28. ISHIBASHI T, Inagaki T, Okazawa M, Yamagishi A, et al
    IL-6/gp130 signaling in CD4(+) T cells drives the pathogenesis of pulmonary hypertension.
    Proc Natl Acad Sci U S A. 2024;121:e2315123121.
    PubMed         Abstract available
    
    

    
    Purinergic Signal

29. BESSA-GONCALVES M, Braganca B, Martins-Dias E, Vinhas A, et al
    Blockage of the adenosine A(2B) receptor prevents cardiac fibroblasts overgrowth in rats with pulmonary arterial hypertension.
    Purinergic Signal. 2024;20:163-179.
    PubMed         Abstract available
    
    

    
    Respir Med

30. STEGER M, Canuet M, Enache I, Goetsch T, et al
    Survival and response to pulmonary vasodilator therapies in patients with chronic obstructive pulmonary disease and pulmonary vascular phenotype.
    Respir Med. 2024;225:107585.
    PubMed         Abstract available
    
    

    
    Thorax

31. GONG S, Li H, Wang L
    Pulmonary artery-pulmonary artery collaterals in chronic thromboembolic pulmonary hypertension.
    Thorax. 2024 Apr 10:thorax-2023-221219. doi: 10.1136/thorax-2023-221219.
    PubMed        
    
    

    
    Vascul Pharmacol

32. MORALES-CANO D, Barreira B, Callejo M, Olivencia MA, et al
    Comparative analysis of antiproliferative and vasodilator effects of drugs for pulmonary hypertension: Extensive in vitro study in rats and human.
    Vascul Pharmacol. 2024 Apr 8:107371. doi: 10.1016/j.vph.2024.107371.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Pulmonary Hypertension is free of charge.